LBT Innovations Ltd
ASX:LBT
LBT Innovations Ltd
ASX:LBT
Price:
0.017
AUD
-5.56%
Market Closed
Market Cap:
AU$29.9m
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently Viewed
|
LBT Innovations Ltd
ASX:LBT
|
AU |
|
G
|
Glenveagh Properties PLC
ISEQ:GVR
|
IE |
|
A
|
Avanza Bank Holding AB
STO:AZA
|
SE |
|
H
|
Hawk Systems Inc
OTC:HWSY
|
US |
|
Beazley PLC
LSE:BEZ
|
UK |
|
Alliance Healthcare Group Ltd
SGX:MIJ
|
SG |
|
Keros Therapeutics Inc
NASDAQ:KROS
|
US |
|
N
|
note Inc
TSE:5243
|
JP |
|
Mayur Resources Ltd
ASX:MRL
|
AU |
|
G
|
Grainger PLC
OTC:GRGTF
|
UK |
|
Shaanxi Coal Industry Co Ltd
SSE:601225
|
CN |
|
S
|
StandardAero, Inc.
NYSE:SARO
|
US |
|
Zhejiang China Commodities City Group Co Ltd
SSE:600415
|
CN |
|
W
|
WEG SA
OTC:WEGZY
|
BR |
|
Abdullah Al Othaim Markets CompanySJSC
SAU:4001
|
SA |
|
S
|
Suzhou Delphi Laser Co Ltd
SSE:688170
|
CN |
|
First Niles Financial Inc
OTC:FNFI
|
US |
|
Top Shelf International Holdings Ltd
ASX:TSI
|
AU |
|
D
|
Datalogic SpA
MIL:DAL
|
IT |
|
S
|
Sekisui Jushi Corp
TSE:4212
|
JP |
|
Z
|
Zhejiang Yasha Decoration Co Ltd
SZSE:002375
|
CN |
|
Shenzhen YHLO Biotech Co Ltd
SSE:688575
|
CN |
|
Hari Govind International Ltd
BSE:531971
|
IN |
|
Chant Sincere Co Ltd
TWSE:6205
|
TW |
Multiples-Based Value
There is not enough data to reliably calculate the multiples-based value of LBT.
Multiples-Based Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.
Relative Valuation FAQ:
LBT
Multiples-Based Value
Base Case
Not Available
Multiples Across Competitors
LBT Competitors Multiples
LBT Innovations Ltd Competitors
LBT Innovations Ltd Competitors
All Countries
| Market Cap | P/S | P/E | EV/EBITDA | EV/EBIT | ||||
|---|---|---|---|---|---|---|---|---|
| AU |
|
LBT Innovations Ltd
ASX:LBT
|
29.9m AUD | 22.8 | -8 | -6.5 | -6.5 | |
| US |
|
Abbott Laboratories
NYSE:ABT
|
180.6B USD | 4.1 | 27.7 | 15.9 | 21.8 | |
| US |
|
Intuitive Surgical Inc
NASDAQ:ISRG
|
160.7B USD | 16 | 56.3 | 42.6 | 52.3 | |
| US |
|
Stryker Corp
NYSE:SYK
|
125.2B USD | 5 | 38.6 | 19.7 | 23.9 | |
| IE |
|
Medtronic PLC
NYSE:MDT
|
111.8B USD | 3.2 | 24.2 | 13.4 | 19.5 | |
| US |
|
Boston Scientific Corp
NYSE:BSX
|
102.6B USD | 5.1 | 35.4 | 20.8 | 28 | |
| US |
|
Edwards Lifesciences Corp
NYSE:EW
|
46.1B USD | 7.6 | 43 | 23.6 | 25.8 | |
| DE |
|
Siemens Healthineers AG
XETRA:SHL
|
41B EUR | 1.7 | 19.1 | 10.8 | 15.2 | |
| US |
|
IDEXX Laboratories Inc
NASDAQ:IDXX
|
44.5B USD | 10.3 | 42 | 29.8 | 33 | |
| US |
|
Becton Dickinson and Co
NYSE:BDX
|
44B USD | 2 | 25 | 9.9 | 16.8 | |
| US |
|
GE Healthcare Technologies Inc
NASDAQ:GEHC
|
31.6B USD | 1.5 | 15.1 | 11 | 13.2 |
P/S Multiple
P/E Multiple
EV/EBITDA Multiple
EV/EBIT Multiple
